This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Newsramp
newsramp.com
did:plc:xlsujlrwr5xpfxgaf4pixhri
NanoViricides to present broad-spectrum antiviral pipeline at D. Boral Capital Global Conference in NYC on May 7. Lead candidate NV-387 completed Phase I trials with zero adverse events. #Biotech #Antivirals
2026-05-15T03:10:16.275Z